Hematology & Oncology Doctors in Kingwood, TX Accepting Medicare

7 Hematology & Oncology doctors found. Showing 1 - 7

Dr. Mary K Crow, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 22710 Professional Dr, Kingwood, TX 77339 Phone: 281-298-8444    Fax: 281-298-7720

Dr. David Peter Ellent, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 22751 Professional Dr Ste 140, Kingwood, TX 77339 Phone: 281-975-1000    Fax: 281-783-2505

Pierre N Khoury, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 22710 Professional Dr, Suite 100, Kingwood, TX 77339 Phone: 281-298-8444    Fax: 281-298-7720

Samer S Suki, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 22710 Professional Dr, Kingwood, TX 77339 Phone: 281-298-8444

Gregory T Seymour, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 22710 Professional Dr, Kingwood, TX 77339 Phone: 281-298-8444    Fax: 281-298-7720

Murtaza N Bhuriwala, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 22710 Professional Dr, Kingwood, TX 77339 Phone: 281-298-8444    Fax: 281-298-7720

Anirudha Dasgupta, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 22710 Professional Dr, Kingwood, TX 77339 Phone: 281-298-8444

News Archive

Real-time blood test based on DNA sequencing can rapidly diagnose Ebola and other acute infections

Using technical advances not yet developed when the 2014 Ebola outbreak began, UC San Francisco-led scientists completed a proof-of-principle study on a real-time blood test based on DNA sequencing that can be used to rapidly diagnose Ebola and other acute infections. The researchers said that the test can be used even where lab space and medical infrastructure are scarce.

Report shows women affected by DCIS prefer nonsurgical treatments

When ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition rather than cancer, more women report that they would opt for nonsurgical treatments, according to a research letter by Zehra B. Omer, B.A., of Massachusetts General Hospital—Institute for Technology Assessment, Boston, and colleagues.

Researchers identify porcine enterovirus G using next-generation sequencing

He calls himself the bug hunter, but the target of his work consists of viruses that can only be found and identified with special methods and instruments.

Cellid, IVI sign research service contract to evaluate immunogenicity of COVID-19 vaccine

Cellid and the International Vaccine Institute have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine "AdCLD-CoV19".

Read more Medical News

› Verified 1 days ago